a

8 things for spine surgeons to know for Thursday — Oct. 12, 2017 Featured

By  Megan Wood | Thursday, 12 October 2017 16:33
Social sharing

Here are eight things for spinal surgeons to know for Oct. 12, 2017.

NuVasive files complaint against former board member who resigned for Alphatec post
NuVasive filed a lawsuit against former President, COO and Vice Chairman Patrick Miles for breach of fiduciary duties and contract violation after the executive resigned from the company to become Alphatec's executive chairman. Read about the case, here.

Alphatec, Patrick Miles fire back at NuVasive, call lawsuit 'baseless' and 'fictional'
Alphatec Holdings responded Oct. 11 to a lawsuit NuVasive filed Oct. 10 against former NuVasive board member and current Alphatec Executive Chairman Patrick Miles. Read their response, here.

Mazor sells 22 systems in Q3, hands over Mazor X distribution to Medtronic
Mazor Robotics received 22 system purchase orders in the second quarter, including 19 for the Mazor X system; Medtronic made 11 of those purchases. Medtronic assumed full responsibility for Mazor X distribution on Sept. 18 and the company ended the quarter with a backlog of 17 systems. Mazor expects to report $17.2 million in third quarter revenue on Nov. 7.

Implanet reports 20% Q3 revenue growth
Implanet reported third quarter revenue grew 20 percent year-over-year. Spine revenue jumped 23 percent in the third quarter while knee and arthroscopy revenue dropped 12 percent overall. Jazz spinal implant sales reported a 30 percent growth in the third quarter, and sales were up around 23 percent for the first nine months of the year.

AxioMed secures $10M in pledges prior to 2nd funding round opening — 4 highlights of the company's viscoelastic disc
AxioMed closed its first round of funding, with its anticipated second round already securing $10 million in pledges. The company closed its oversubscribed first round quickly following great interest in its lateral viscoelastic disc replacement and multi-level cervical investigational device exemption trial.

Renew Spinal Care, SpineMark enter strategic alliance
Houston-based Renew Spinal Care and SpineMark Corp. entered a strategic alliance agreement. The two companies will foster a mutually aligned mission of improving patient diagnosing, integrating minimally invasive spine surgery protocol and merging medical technology.

OrthoNY seeks approval for $5.6M ASC, projects $5.8M revenue in 1st year
OrthoNY published to expand its orthopedic practice with a new multispecialty ASC. The practice submitted an application to the New York Public Health and Health Planning Council to seek contingent approval for their new project: a 12,000-square-foot ASC. The project is expected to cost $5.6 million and bring in around $5.8 million in revenue for the first year.

Key findings on cost, length of stay for Medicare beneficiaries undergoing cervical spinal fusion
A new study published in Spine examines the outcomes and length of stay for Medicare beneficiaries undergoing cervical spinal fusion. Of all Medicare beneficiaries examined in the study, 6.2 percent reported at least one adverse event. Study authors found adverse events frequently occurred among Medicare beneficiaries undergoing two and three level spinal fusions, and recommended shared decision making to clearly provide the risks for patients considering undergoing these procedures.

More articles on spine:
ORHub names Dr. Vikram Udani to advisory board — 5 notes
5 key findings on cost, length of stay for Medicare beneficiaries undergoing cervical spinal fusion
'A Call for Change' campaign addresses greatest pain management issues — 5 takeaways

 

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months